Long-acting injectable antipsychotics: what, when, and how – CORRIGENDUM

Leslie Citrome

doi:10.1017/S1092852921000778

Long-acting injectable antipsychotics: what, when, and how – CORRIGENDUM

Published online by Cambridge University Press: 16 September 2021

Leslie Citrome

Article contents

Abstract
References

Rights & Permissions

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type: Corrigendum
Information: CNS Spectrums , Volume 27 , Issue 6 , December 2022 , pp. 764

DOI: https://doi.org/10.1017/S1092852921000778 [Opens in a new window]
Copyright: © The Author(s), 2021. Published by Cambridge University Press

In the above article,Reference Citrome¹ there was an error in Table 6. In the row “Paliperidone palmitate, 9 and 13 wk” and the “drug” column of the “Somnolence/Sedation Adverse Events” section, the number should read 4.7^a and not 8.7^a.

References

Citrome, L. (2021). Long-acting injectable antipsychotics: what, when, and how. CNS Spectrums. 26(2):118–129. doi:10.1017/S1092852921000249.CrossRef Google Scholar PubMed

This correction applies to the following article(s):

Long-acting injectable antipsychotics: what, when, and how

Leslie Citrome Leslie Citrome

CNS Spectrums , Volume 26 , Issue 2

Article contents

Long-acting injectable antipsychotics: what, when, and how – CORRIGENDUM

Abstract

Information

References

This correction applies to the following article(s):

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests